INFOTEHNA's Pharmaceutical Conference, biggest annual event of INFOTEHNA Group, happened from 25-27 May by the shore of the crystalline alpine lake Woerthersee on the outskirts of Klagenfurt, capital of the federal state of Carinthia in Austria. Combination of picturesque historical location and brand new modern Lindner Seepark Hotel provided perfect background setting for 3 days of workshops, presentations and meetings.
INFOTEHNA Group will be present at 17th EGA ANNUAL CONFERENCE titled "Generic Medicines Enhancing Pharmaceutical Competition and Ensuring Healthcare Sustainability", which will take place in Lisbon – Cascais, from 15 to 17 June. Preconference day will be dedicated to Pharmaceutical Patent Litigation Seminar: a Statistical and Practical Approach.
INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, is proud to announce that it has recently completed its 300th QuickStart® Camp, which is a unique, week-long kick-off meeting with the customer that is designed to reconcile expectations and build study ownership by the entire project team right up front. QuickStart Camp is part of the second phase in INC Research's Trusted Process®, the company's proven, metrics-driven clinical trial outsourcing methodology. When compared to industry benchmarks established by CMR International Institute for Regulatory Science, customers experience 35 percent faster project startup time after experiencing QuickStart.
INC Research, LLC, a therapeutically focused global contract research organization (CRO) privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, and Kendle International Inc. (Nasdaq: KNDL), today jointly announced a definitive merger agreement under which INC Research will acquire Kendle in an all-cash transaction with a total equity value of approximately $232 million. Kendle is a leading global CRO with extensive expertise in Phase I-IV clinical development and more than 3,000 associates in 31 countries worldwide.
INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, today announced the acquisition of Trident Clinical Research to expand its clinical trials outsourcing footprint and expertise in Australia, New Zealand and India. Under the terms of the agreement, Trident will become a wholly owned affiliate of INC Research and will operate as Trident Clinical Research, an INC Research company through its offices in Sydney, Brisbane, Melbourne, Adelaide, Auckland and Mumbai. Trident’s operation in Mumbai will increase the reach of INC Research’s already sizeable clinical and data operations located in Gurgaon, India.
Alliance Life Sciences Consulting Group, a leading management and technology consultancy, delivered today a comprehensive recommendation of organizational and process enhancements to a midmarket pharmaceutical client for potentially more than $1 million annually in saved revenue leakage, while allowing the manufacturer to pursue new contracting strategies expected to deliver more than $12 million annually in increased revenue.
Key members of the Revenue Contract Management Practice at Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, will present “Implementation Readiness –How to Start on the Right Track,” focusing on preventing major risks that can disrupt Revenue Contract Management Implementations during iMANY Summit 2011, on Tuesday, May 24th at 2:40 p.m., at the Fontainebleau Miami Beach, Miami Beach, FL.
Haupt Pharma, one of Europe's leading contract developers and manufacturers, has successfully passed an inspection by the US Food and Drug Administration (FDA) at its site in Regensburg / Germany without any FDA-483 observation being issued.
Sweden’s YKI, Institute for Surface Chemistry, a subsidiary of the SP Technical Research Institute of Sweden, is combining the benefits of the Mastersizer 2000 and Zetasizer Nano particle characterization systems from Malvern Instruments, in order to aid their customers in developing stable products with improved physical properties. Specializing in industrial research in applied surface and colloid chemistry, the group has been set up to close the gap between formulation and colloid science, by applying the principles of colloid science to industrial and pharmaceutical product development.
A new 3-minute video highlighting the versatility of the Parsum IPP 70 In-line Particle Probe is now available on the Malvern Instruments website. Designed to measure continuously the size, size distribution, and velocity of granular particles, directly in the process, the Parsum In-line Particle Probe (IPP) is a valuable tool for process development and automated production. It has applications in many sectors including the food, chemical and pharmaceutical industries.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.